Skip to content

Breast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer Survivors

A Pilot Study to Evaluate the Feasibility of a Breast Cancer Rehabilitation Program in Survivors of Breast Cancer

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01113554
Enrollment
26
Registered
2010-04-30
Start date
2010-06-30
Completion date
2012-11-30
Last updated
2018-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer

Brief summary

RATIONALE: A breast cancer rehabilitation program and exercise therapy may help improve the quality of life of breast cancer survivors. PURPOSE: This clinical trial studies a breast cancer rehabilitation program in improving quality of life in breast cancer survivors.

Detailed description

PRIMARY OBJECTIVES: I. To estimate accrual, retention, adherence, and participation of breast cancer survivors to a breast cancer rehabilitation program. II. To estimate the variability of weight, six-minute walk, quality of life and other psychosocial and physical measures in women participating in the BCRP. SECONDARY OBJECTIVES: I. To assess changes in the anthropometric, psychosocial, and physical outcomes over the six-month period of the BCRP. II. To document the types and the rates of adverse events associated with the BCRP. OUTLINE: Patients attend exercise therapy sessions over 1 hour 3 times a week for 6 months. Exercise therapy sessions are comprised of a 10 minute warm-up of light stretching and aerobic type exercise (walking, cycling), 30 minutes of endurance type exercise (cycle, walking), and 20 minutes of resistance training exercise.

Interventions

OTHERquestionnaire administration
BEHAVIORALexercise intervention
PROCEDUREquality-of-life assessment
OTHERsurvey administration
PROCEDUREmanagement of therapy complications
PROCEDUREpsychosocial assessment and care

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Inclusion * First occurrence of breast cancer * BMI \>= 25 * Recently completed treatment(chemotherapy/radiation) for breast cancer (=\< 8 weeks), but can be receiving adjuvant hormonal therapy * Willing to comply with study visits, as outlined in the protocol * Lives within 30 miles of study site, or willing to travel to study site if outside a 30-mile radius * Ability to participate in a moderate exercise program, such as freedom from any orthopedic abnormalities that would prevent participation * Ability to understand and the willingness to sign a written informed consent document Exclusion * Unstable angina * Cardiac conduction disturbances * Plans to move from the study area * Dementia that is medically documented or suspected * Advanced arterial disease causing ischemia of any limb * Physical immobility * Homebound for medical reasons * Dependent on wheelchair for mobility * Chronic disease which significantly reduces 4-year survival * Recurrent breast cancer

Design outcomes

Primary

MeasureTime frame
Ability to recruit breast cancer survivors into a six-month breast cancer rehabilitation programApproximately 24 months
BMI6 months
Muscular strength6 months
Range of motion6 months
Quality of life6 months
Proportion of screened women who are eligible for the study and the proportion of eligible women who agree to participateApproximately 24 months
Proportion of women who complete the study and the average number of weeks of participationApproximately 24 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026